Clinical Trial on Agitation in Alzheimer's Dementia

计划入组 164 人 · 首次发布于 2022 年 9 月 16 日

Study of IGC-AD1 in Subjects With Dementia Due to Alzheimer's Disease

计划入组 12 人 · 首次发布于 2021 年 2 月 11 日

Pharma-Pen (Formerly Innoject) Auto-injectory TIV

首次发布于 2006 年 6 月 12 日

IGC-504

IGC-512

IGC-510

IGC Pharma LLC

United States

ACASTI PHARMA INC

United States

Innate Pharma, Inc.

United States

IGC Pharma's IGC-1C Targets Novel Tau Protein Pathway in Alzheimer's Disease

IGC Pharma Unveils AI-Powered Alzheimer's Platforms at AAIC 2025

IGC Pharma Reports Promising Interim Results for Alzheimer's Agitation Therapy